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Purpose/Objective: The aim of this study is to assess the 
stability of relative gold marker position due to deformation 
and marker migration for prostate cancer during the 
treatment course of image-guided VMAT external beam 
radiotherapy. 
Materials and Methods: 30 patients with localized prostate 
cancer, who underwent primary IGRT with implanted gold 
markers (MPB Marker Kit 1.2x3mm, MPB Scherer 
Medizinprodukte GmbH, A-Krustetten), were chosen for this 
study. 27 patients had four and three patients had three 
implanted markers. The gold marker implantation was 
carried out one week before the planning CT. The IGRT was 
carried out with kV-CBCT and orthogonal kV-Imaging (OBI 
Varian Medical Systems, Palo Alto CA). For this study 739 
orthogonal kV-image pairs were evaluated: between 9 and 32 
kV image pairs were evaluated per patient. The images were 
segmented with an edge algorithm (MATLAB R2013a, 
MathWorks). The centroid of the gold marker was identified 
to evaluate the gold marker position. The inter-marker 
distances were determined and compared to those identified 
in the planning CT. 
Results: The median marker distance was 23.9 ± 9.7 mm 
(SD). The marker distance varied from 5.5 to 45.7 mm. For 21 
patients the marker distance variations remained under 3 
mm. For five patients marker distance variations between 3 
and 4 mm were identified. The variation exceeded 4 mm for 
four patients. For one of them the variation seemed to be the 
result of either prostate deformation related to organ filling 
in the planning CT or gold marker migration after the 
planning CT. In this case the mean distance variation 
between two markers was 5.7 ± 0.5mm (SD). Overall 640 of 
739 IGRT sessions showed deviations in marker distance 
variation below 3 mm. 67 distance variations were between 3 
and 4 mm. In 32 IGRT sessions the inter-marker distance 
exceeded 4 mm. 
Conclusions: In most cases the gold marker distance 
variation seems to be smaller than 3 mm, so that a good 
image matching can be achieved. If the variation exceeds 3 
mm the matching might become more difficult. 
For patients with larger variation it should be determined if 
the change is the result of gold marker migration. 
Furthermore, if necessary, a new planning CT should be 
performed and the PTV margins appropriately adapted. 
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Purpose/Objective: The use of fiducials markers (FM) as 
surrogate for prostate position in IGRT modality requires a 
stable markers position within the gland.  
Aim of this study was to assess the marker migration during 
the full course of prostate radiotherapy. 
Materials and Methods: The analysis was performed on 55 
low risk cT1-2 prostate cancer patients, treated with Image 
Guided Radiotherapy between June 2009 and May 2014. 
Three markers per patient were implanted at the base (A), 
middle (B) and apex (C) of the gland. All patients underwent 
computed tomography (CT sim) 1-mm thickness, ≥1 week 
after implantation; a daily CBCT was used to check markers 
position before each treatment session . Retrospectively CT 
sim and CBCTs acquired at 1st , 10th , 20th , 30th and 39th 
fraction were used to record FM coordinates (x,y,z). The 
distances between markers (FMD) as AB, BC, CA were 
measured as:  
 
 
FMDs variations during the full course of radiotherapy were 
then calculated as the differences between CBCTs and CTs 
data.  
 
Results: The average absolute variation of all FMDs was 
1,20±0,67 mm. The largest observed variation in FMD was 
8,96 mm. 94% of recorded variations were 3 mm or less , 
while 80% 2 mm or less. A simultaneous progressive reduction 
of FMDs was seen in 77% of patients and it was related to the 
shrinking of the prostate volume during the treatment (Fig 
1). No correlation was found between FMD variations and 
initial prostate volume. Smaller variations were recorded in 
patients with at least 10 days gap between markers 
implantation and CT acquisition due to the edema reduction. 
 
 
 
 
Conclusions: The obtained results indicates small variations 
in the relative position of the markers (1,20±0,67 mm) 
without a significant marker migration. 
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